title: BRAFV600E mutation is rare in clear cell ovarian carcinoma, but could potentially be identified with mutation specific immunohistochemistry.
authors: 1Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research, St Leonards 2Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards 3Sydney University Medical School, University of Sydney 4Sydney Vital Translational Research Centre, Kolling Institute of Medical Research, St Leonards, NSW, Australia.
authors: Tristan
authors: T
authors: Dodds
authors: Lisa
authors: L
authors: D'Urso
authors: Anthony J
authors: AJ
authors: Gill
mesh_terms: D018262:Adenocarcinoma, Clear Cell / Q000235:genetics*; D004252:DNA Mutational Analysis / Q000379:methods; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D010051:Ovarian Neoplasms / Q000235:genetics*; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D046888:Tissue Array Analysis
chemical_list: C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf